Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Safety and PK of BWC0977 in Healthy Volunteers
NCT05088421Phase 1Completed
- Sponsor
- Bugworks Research Inc.
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in bacterial infection comparing BWC0977 with Placebo (2 arms). Primary endpoint: Treatment-emergent adverse events up to 15 days. Started Nov 2021; status: completed.
02
Drugs
BWC0977
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05088421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05088421.